January 2020 News New Pharmacy Partnership Optimizes Patient Care Through Data Driven Solutions
Avricore Health and the Ontario Pharmacists Association are delivering innovations in pharmacy practice through point-of-care testing technology
VANCOUVER, British Columbia, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are pleased to announce the finalized partnership agreement to promote HealthTab™, a point-of-care blood screening tool for pharmacies.
This agreement follows the previously announced Memorandum of Understanding signed between the two parties on November 28, 2019, where OPA agreed to promote Avricore’s point-of-care testing platform, HealthTab™ + RASTR Network.
Under this agreement the Company agrees to remunerate OPA for new locations secured through facilitated introductions, plus a per test fee upon system implementation. Additionally, the two organizations will work jointly to leverage statistical data generated for research purposes to support OPA member insights and patient policy advocacy.
“This is the first partnership of this kind for us and we could not have asked for a better partner than the largest professional association of pharmacists in the country,” says Avricore Health’s CEO, Hector Bremner. “We’re looking forward to supporting even more patients access this important innovation in healthcare.”
By offering HealthTab™ to their patients, a pharmacist is able to modernize their practice through advancements in point-of-care testing, as well as address the high consumer demand for easier access to health data supporting evidence-based care.
Pharmacies that engage with Avricore agree to a two-year lease commitment of HealthTab, as well as the purchase of lipid and metabolic panels and other consumables from the Company.
“It’s clear that the entire healthcare sector is at an important moment, where social, economic and regulatory changes are having a big impact on both professionals and their patients,” says OPA CEO, Justin Bates. “Through partnerships like this, OPA members are leading the way for innovation in pharmacy."
FAST FACTS
- Avricore’s revolutionary HealthTab™ point-of-care blood screening platform is ideal for screening consumers for the early signs of diabetes, heart attack and stroke risk, as well as liver and kidney function concerns.
- The in-pharmacy HealthTab™ test delivers 21 key bio-markers using a finger stick, with results being available after 12 minutes via a secure log in.
- De-identified data across the network of analyzers can be used for research purposes, creating the first real-time, real-world evidence platform for treated population studies, research and development.
Pharmacies with HealthTab™ in their locations were polled to tell us the biggest advantages they found to offering the system. Here’s the top outcomes for them:
- Drives prescriptions
- Increases customer loyalty
- Increases medication review billing and other clinical services revenue
- Improves inter-professional collaboration with primary care providers
- Improves pharmacy customer service index
- Improves overall patient health through screening, chronic disease management, and medication optimization
- Improves medication adherence and frequency of script refills
- Increases traffic to pharmacy
- Increases overall pharmacy blended margin
With easier access to regular screening, patients and their healthcare teams, including their trusted pharmacist, can take action to improve health outcomes and lower the risk of serious illness.